about
Towards control of schistosomiasis in sub-Saharan Africa.Role of the employment status and education of mothers in the prevalence of intestinal parasitic infections in Mexican rural schoolchildrenHeterogeneities in the transmission of infectious agents: implications for the design of control programs.The importance of models of infection in the study of disease resistance.Schistosomiasis control: keep taking the tablets.Adult schistosome cDNA libraries as a source of antigens for the study of experimental and human schistosomiasis.Partial characterization and kinetics of expression of Sm15, a Schistosoma mansoni tegumental antigen.Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs.P38 mitogen-activated protein kinase influence on the production of IL-10 in human schistosomiasis mansoni.Comparative proteomics profiling of a gentamicin-attenuated Leishmania infantum cell line identifies key changes in parasite thiol-redox metabolism.Leishmania major H-line attenuated under pressure of gentamicin, induces a Th1 response which protects susceptible BALB/c mice against infection with virulent L. major.Prospects for immunological control of schistosomiasis.Structure of the gene encoding a putative Schistosoma mansoni tegumental antigen precursor.Counterfeit praziquantel.Gentamicin-attenuated Leishmania infantum: a clinicopathological study in dogs.Chemotherapy-induced, age-related changes in antischistosome antibody responses.Contrasting cellular responses in Schistosoma haematobium infected and exposed individuals from areas of high and low transmission in Zimbabwe.Eosinophilic interleukin 5 (IL-5) transgenic mice: eosinophil activity and impaired clearance of Schistosoma mansoni.Gentamicin-attenuated Leishmania infantum: cellular immunity production and protection of dogs against experimental canine leishmaniasis.Changes in specific anti-egg antibody levels following treatment with praziquantel for Schistosoma haematobium infection in children.Praziquantel--its use, cost and possible development of resistance.Detection of the parasitic dinoflagellate Hematodinium in the Norway lobster Nephrops norvegicus by ELISA.Schistosomiasis Vaccines: A Response to a Devils’ Advocate’s View a aNB see Letters, this issuePrevalence and intensity of intestinal parasitic infections in relation to nutritional status in Mexican schoolchildrenLeishmania mexicanaandLeishmania major:Attenuation of Wild‐Type Parasites and Vaccination with the Attenuated LinesInfectious diseases: back to the future?A novel and sensitive method to monitor helminth infections by faecal samplingDissociation of interleukin-4 and interleukin-5 production following treatment for Schistosoma haematobium infection in humansSchistosomiasis Research: The End of the BeginningA simple method for counting cells in tissue sectionsA differential staining method for mast cells and eosinophils in murine intestine, liver and spleenFixing and staining mast cells and eosinophils in murine tissuesConcomitant immunity in schistosomiasisSurface and species-specific antigens of Schistosoma haematobiumHymenolepis citelli (cestoda) and Nematospiroides dubius (Nematoda): Interspecific interaction in miceNematospiroides dubius: Effect of infection on lymphocyte responses to Trichinella spiralis in mice
P50
Q30862703-2791A788-ACF5-4806-BF48-0A0B1DE4C378Q33256573-F8B8831F-2E75-470B-8B75-040BD3691788Q34413014-5972CF3F-BBAF-4C42-BA9F-AC319954E6F0Q34960344-01ABF226-8AC6-431D-819E-9FE776E1A31AQ35640594-EA33E854-97CA-430F-A386-6710B5D0C94EQ36418742-761293E9-E54B-4965-A820-C22165F085FAQ36746803-915EA4B6-E44F-429E-A02C-1EB5912DA298Q37413446-23DB7A07-503E-4A88-A0F7-0CCF8389E0C4Q38932463-A57AA67D-0C10-44AA-BEF6-BD5E94FBCDFDQ39431075-5BBEA70B-5A32-4334-808A-E0E0994CD4A1Q39818399-C0610582-BB91-485B-A354-51622CE566E2Q40538544-B5C3C63B-2B99-486F-9EC7-03634DF5B516Q42614945-DA6D1FBB-CC36-48A6-9285-27EDE5EE9E17Q43729546-2B65B0B4-3D8C-46ED-BFD0-25DDC4676504Q44090267-B2BE3900-226F-456B-8324-2A0146F41EBCQ44468424-35814E48-1289-477D-A904-6145D7503DBBQ44503291-03B22E22-09D5-4B91-98CB-C72FEA06959DQ44525875-6167F72E-05D4-45FE-9397-F27DD9B50109Q44895414-85185077-C619-4585-ACE8-E13D7167C699Q50532513-99F33590-A808-4E42-B67B-24AE878C4CBFQ52572478-5BDC53C4-D487-4033-AEDA-66458E70D250Q53142167-5720119B-7F30-4B20-B535-E79E54BFD160Q56835733-D3ED4815-9019-4FAB-BFF0-5BBEB447B3C8Q57250585-5BD679F5-E4B8-4B1D-BF98-7571B3079AFBQ57250587-689D2A79-5A4C-40C3-AECF-105522DF6B7AQ57250594-41E2E91A-3C6B-4164-808A-14C670DC92D5Q57250598-31A05FAA-BE04-430A-A72D-8227FA7FB074Q57250612-2A22AB26-FC54-48AD-9717-0E07B8B3F6D7Q57250629-26118E51-C608-4152-9873-168D9B1D7B3FQ57250631-10792B68-B1BB-4FFC-A950-9D4DE8425BBEQ57250644-98094781-BCE9-48CB-B559-4167BD36D9D2Q57250646-12CC04A4-AA5A-4E87-8845-530CD1FE1EC1Q57250652-9FE736E6-895C-400B-AC29-5D5BFFDF90AFQ57250663-D256828C-7652-4C1D-95AA-C31FE8A57CA7Q57250669-FCE79C90-6EE5-4423-8624-4A15C2A6CD52Q57250673-8C8539A0-DC99-48BE-842B-F0A50735FE89
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
P Hagan
@ast
P Hagan
@en
P Hagan
@es
P Hagan
@nl
P Hagan
@sl
type
label
P Hagan
@ast
P Hagan
@en
P Hagan
@es
P Hagan
@nl
P Hagan
@sl
prefLabel
P Hagan
@ast
P Hagan
@en
P Hagan
@es
P Hagan
@nl
P Hagan
@sl
P106
P1153
35603032200
7006106331
P31
P496
0000-0002-3516-2283